AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Citadel Group

Major Shareholding Notification Nov 6, 2025

10454_rns_2025-11-06_7446f66c-8d3f-4b0e-a34a-927f887f5d65.html

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 5174G

Citadel Group

06 November 2025

Ap27

FORM 8.3

IRISH TAKEOVER PANEL

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.             KEY INFORMATION

(a)   Full name of discloser Citadel Group
(b)   Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
N/A
(c)   Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree
AVADEL PHARMACEUTICALS PLC
(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1) N/A
(e)   Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure
5 November 2025
(f)    In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"
N/A

2.             INTERESTS AND SHORT POSITIONS

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Ap28

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

Class of relevant security

(Note 3)
Common Stock ISIN IE00BDGMC594

$0.01 ordinary shares
Interests Short positions
Number % Number %
(1)   Relevant securities owned and/or controlled 1,831,478 1.87 446,884 0.45
(2)   Cash-settled derivatives 0 0.00 0 0.00
(3)   Stock-settled derivatives (including options) and agreements to purchase/ sell 172,200 0.17 1,455,100 1.49
Total 2,003,678 2.05 1,901,984 1.94

All interests and all short positions should be disclosed.

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

3.             DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)           Purchases and sales

Class of relevant

security
Purchase/sale Number of

securities
Price per unit

(Note 5)
Common Buy Transaction 16,460 18.8900 USD
Common Buy Transaction 166 18.9000 USD
Common Buy Transaction 725 18.9003 USD
Common Buy Transaction 18 18.9028 USD
Common Buy Transaction 2,227 18.9045 USD
Common Buy Transaction 125 18.9073 USD
Common Buy Transaction 5 18.9100 USD
Common Buy Transaction 10 18.9140 USD
Common Buy Transaction 104 18.9150 USD
Common Buy Transaction 112 18.9151 USD
Common Buy Transaction 705 18.9157 USD
Common Buy Transaction 4,118 18.9184 USD
Common Buy Transaction 1,207 18.9200 USD
Common Buy Transaction 658 18.9212 USD
Common Buy Transaction 19 18.9237 USD
Common Buy Transaction 1,000 18.9240 USD
Common Buy Transaction 158 18.9249 USD
Common Buy Transaction 606 18.9250 USD
Common Buy Transaction 300 18.9250 USD
Common Buy Transaction 283 18.9250 USD
Common Buy Transaction 593 18.9267 USD
Common Buy Transaction 4 18.9275 USD
Common Buy Transaction 7 18.9286 USD
Common Buy Transaction 16 18.9294 USD
Common Buy Transaction 2,125 18.9300 USD
Common Buy Transaction 512 18.9300 USD
Common Buy Transaction 614 18.9301 USD
Common Buy Transaction 31 18.9339 USD
Common Buy Transaction 1,453 18.9343 USD
Common Buy Transaction 222 18.9349 USD
Common Buy Transaction 55 18.9351 USD
Common Buy Transaction 131 18.9351 USD
Common Buy Transaction 1,765 18.9359 USD
Common Buy Transaction 157 18.9375 USD
Common Buy Transaction 102 18.9378 USD
Common Buy Transaction 71 18.9400 USD
Common Buy Transaction 2,690 18.9418 USD
Common Buy Transaction 99 18.9451 USD
Common Buy Transaction 351 18.9454 USD
Common Buy Transaction 41 18.9471 USD
Common Buy Transaction 55 18.9482 USD
Common Buy Transaction 13 18.9485 USD
Common Buy Transaction 584 18.9496 USD
Common Buy Transaction 985 18.9499 USD
Common Buy Transaction 1,213 18.9500 USD
Common Buy Transaction 1,333 18.9508 USD
Common Buy Transaction 836 18.9554 USD
Common Buy Transaction 61 18.9570 USD
Common Buy Transaction 401 18.9576 USD
Common Buy Transaction 217 18.9578 USD
Common Buy Transaction 19,347 18.9600 USD
Common Buy Transaction 475 18.9611 USD
Common Buy Transaction 600 18.9650 USD
Common Buy Transaction 46 18.9652 USD
Common Buy Transaction 800 18.9662 USD
Common Buy Transaction 181 18.9664 USD
Common Buy Transaction 2,950 18.9700 USD
Common Buy Transaction 498 18.9742 USD
Common Buy Transaction 907 18.9745 USD
Common Buy Transaction 490 18.9800 USD
Common Buy Transaction 784 18.9849 USD
Common Buy Transaction 800 18.9900 USD
Common Buy Transaction 512 18.9939 USD
Common Buy Transaction 400 18.9950 USD
Common Buy Transaction 200 19.0000 USD
Common Sell Transaction 8,230 18.8900 USD
Common Sell Transaction 4,000 18.9000 USD
Common Sell Transaction 200 18.9100 USD
Common Sell Transaction 312 18.9150 USD
Common Sell Transaction 400 18.9163 USD
Common Sell Transaction 535 18.9163 USD
Common Sell Transaction 307 18.9167 USD
Common Sell Transaction 158 18.9174 USD
Common Sell Transaction 1,412 18.9200 USD
Common Sell Transaction 658 18.9212 USD
Common Sell Transaction 606 18.9217 USD
Common Sell Transaction 319 18.9224 USD
Common Sell Transaction 53 18.9243 USD
Common Sell Transaction 101 18.9250 USD
Common Sell Transaction 266 18.9259 USD
Common Sell Transaction 10 18.9260 USD
Common Sell Transaction 114 18.9261 USD
Common Sell Transaction 1,225 18.9282 USD
Common Sell Transaction 383 18.9300 USD
Common Sell Transaction 146 18.9312 USD
Common Sell Transaction 432 18.9325 USD
Common Sell Transaction 102 18.9350 USD
Common Sell Transaction 11 18.9355 USD
Common Sell Transaction 453 18.9358 USD
Common Sell Transaction 95 18.9365 USD
Common Sell Transaction 344 18.9400 USD
Common Sell Transaction 300 18.9417 USD
Common Sell Transaction 2 18.9450 USD
Common Sell Transaction 1,056 18.9462 USD
Common Sell Transaction 251 18.9469 USD
Common Sell Transaction 400 18.9475 USD
Common Sell Transaction 597 18.9489 USD
Common Sell Transaction 1,736 18.9500 USD
Common Sell Transaction 110 18.9509 USD
Common Sell Transaction 153 18.9521 USD
Common Sell Transaction 150 18.9537 USD
Common Sell Transaction 645 18.9547 USD
Common Sell Transaction 800 18.9550 USD
Common Sell Transaction 75 18.9556 USD
Common Sell Transaction 304 18.9568 USD
Common Sell Transaction 1,691 18.9578 USD
Common Sell Transaction 406 18.9583 USD
Common Sell Transaction 2,131 18.9590 USD
Common Sell Transaction 77 18.9596 USD
Common Sell Transaction 201 18.9600 USD
Common Sell Transaction 4,575 18.9600 USD
Common Sell Transaction 352 18.9650 USD
Common Sell Transaction 855 18.9673 USD
Common Sell Transaction 89 18.9687 USD
Common Sell Transaction 1,053 18.9690 USD
Common Sell Transaction 891 18.9700 USD
Common Sell Transaction 42 18.9729 USD
Common Sell Transaction 5 18.9760 USD
Common Sell Transaction 211 18.9783 USD
Common Sell Transaction 101 18.9799 USD
Common Sell Transaction 1,696 18.9800 USD
Common Sell Transaction 200 18.9900 USD
Common Sell Transaction 828 19.0000 USD

Ap29

(b)           Cash-settled derivative transactions

Class of

relevant

security
Product

description

e.g. CFD
Nature of dealing

e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position
Number of

reference

securities

(Note 6)
Price

per unit

(Note 5)

(c)           Stock-settled derivative transactions (including options)

(i)            Writing, selling, purchasing or varying

Class of

relevant

security
Product

description e.g. call

option
Writing, purchasing, selling, varying

etc.
Number

of

securities

to which

option

relates

(Note 6)
Exercise

price per

unit
Type

e.g.

American,

European

etc.
Expiry

date
Option

money

paid/

received per unit
Common Call Option Buy Transaction 300 20.0000 USD American 2027-01-15 0.4700 USD
Common Call Option Buy Transaction 300 17.5000 USD American 2025-11-21 1.5000 USD
Common Call Option Buy Transaction 200 15.0000 USD American 2025-11-21 4.0000 USD
Common Put Option Sell Transaction 20,000 5.0000 USD American 2026-01-16 0.0500 USD
Common Put Option Sell Transaction 30,000 5.0000 USD American 2026-01-16 0.0900 USD

(ii)           Exercise

Class of

relevant

security
Product

description

e.g. call

option
Exercising/

exercised

against
Number of

securities
Exercise

price per

unit

(Note 5)

(d)           Other dealings (including transactions in respect of new securities) (Note 3)

Class of

relevant

security
Nature of dealing

e.g. subscription,

conversion, exercise
Details Price per unit (if

applicable)

(Note 5)

Ap30

4.             OTHER INFORMATION

(a)           Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
None

(b)           Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None

(c)           Attachments

Is a Supplemental Form 8 attached? YES
Date of disclosure 6 November 2025
Contact name Paula Santos
Telephone number 020 7645 9700

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

Ap32

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2022

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

1.             KEY INFORMATION

Full name of person making

disclosure:
Citadel Group
Name of offeror/offeree in relation

to whose relevant securities the

disclosure relates:
AVADEL PHARMACEUTICALS PLC

2.             STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of

relevant

security
Product

description

e.g. call

option
Written or

purchased
Number of

securities to

which option

or derivative

relates
Exercise

price

per unit
Type

e.g.

American,

European

etc.
Expiry

date
Common Put Option Purchased 0 10.0 USD American 20/03/2026
Common Call Option Purchased 200 25.0 USD American 21/11/2025
Common Put Option Purchased -2,900 7.5 USD American 19/12/2025
Common Put Option Purchased -1,000 25.0 USD American 20/03/2026
Common Put Option Purchased -3,100 12.5 USD American 20/03/2026
Common Put Option Purchased 0 20.0 USD American 21/11/2025
Common Put Option Purchased -60,700 15.0 USD American 16/01/2026
Common Call Option Purchased 0 5.0 USD American 16/01/2026
Common Put Option Purchased -300 15.0 USD American 21/11/2025
Common Call Option Purchased 2,200 20.0 USD American 18/06/2026
Common Put Option Purchased -100 15.0 USD American 15/01/2027
Common Call Option Purchased 7,200 7.5 USD American 21/11/2025
Common Put Option Purchased -100 7.5 USD American 20/03/2026
Common Call Option Purchased 200 22.5 USD American 16/01/2026
Common Put Option Purchased -100 20.0 USD American 18/06/2026
Common Call Option Purchased 3,100 25.0 USD American 15/01/2027
Common Put Option Purchased -4,700 15.0 USD American 19/12/2025
Common Put Option Purchased 0 12.5 USD American 15/01/2027
Common Put Option Purchased -200 17.5 USD American 20/03/2026
Common Put Option Purchased -4,600 12.5 USD American 21/11/2025
Common Call Option Purchased 5,600 12.5 USD American 15/01/2027
Common Call Option Purchased 5,100 15.0 USD American 15/01/2027
Common Put Option Purchased -1,000 17.5 USD American 18/06/2026
Common Call Option Purchased 24,200 22.5 USD American 20/03/2026
Common Put Option Purchased -45,000 10.0 USD American 16/01/2026
Common Put Option Purchased -3,800 15.0 USD American 20/03/2026
Common Call Option Purchased 5,800 22.5 USD American 15/01/2027
Common Call Option Purchased 900 7.5 USD American 19/12/2025
Common Call Option Purchased 0 25.0 USD American 20/03/2026
Common Call Option Sold -100 35.0 USD American 16/01/2026
Common Call Option Sold -30,000 15.0 USD American 20/03/2026
Common Call Option Sold -100 25.0 USD American 19/12/2025
Common Call Option Sold -7,600 10.0 USD American 19/12/2025
Common Call Option Sold -184,000 10.0 USD American 16/01/2026
Common Call Option Sold -165,900 20.0 USD American 21/11/2025
Common Call Option Sold -2,100 12.5 USD American 20/03/2026
Common Call Option Sold -9,600 7.5 USD American 16/01/2026
Common Put Option Sold 24,900 7.5 USD American 16/01/2026
Common Call Option Sold -14,400 10.0 USD American 15/01/2027
Common Call Option Sold -35,400 5.0 USD American 15/01/2027
Common Call Option Sold -52,000 15.0 USD American 19/12/2025
Common Call Option Sold -1,900 17.5 USD American 16/01/2026
Common Call Option Sold -3,400 22.5 USD American 21/11/2025
Common Call Option Sold -1,700 30.0 USD American 21/11/2025
Common Call Option Sold -1,700 25.0 USD American 16/01/2026
Common Call Option Sold -10,100 17.5 USD American 20/03/2026
Common Call Option Sold -4,800 17.5 USD American 15/01/2027
Common Put Option Sold 1,600 12.5 USD American 19/12/2025
Common Call Option Sold -5,400 20.0 USD American 20/03/2026
Common Call Option Sold -31,500 15.0 USD American 21/11/2025
Common Put Option Sold 11,800 17.5 USD American 21/11/2025
Common Put Option Sold 4,400 17.5 USD American 16/01/2026
Common Call Option Sold -2,300 30.0 USD American 16/01/2026
Common Call Option Sold -10,700 7.5 USD American 15/01/2027
Common Put Option Sold 8,200 10.0 USD American 19/12/2025
Common Call Option Sold -4,400 22.5 USD American 19/12/2025
Common Call Option Sold -150,600 15.0 USD American 16/01/2026
Common Put Option Sold 59,000 5.0 USD American 16/01/2026
Common Call Option Sold -44,000 20.0 USD American 16/01/2026
Common Call Option Sold -65,900 12.5 USD American 16/01/2026
Common Call Option Sold -6,200 12.5 USD American 19/12/2025
Common Put Option Sold 100 10.0 USD American 21/11/2025
Common Put Option Sold 400 20.0 USD American 20/03/2026
Common Call Option Sold -219,200 12.5 USD American 21/11/2025
Common Call Option Sold -800 20.0 USD American 19/12/2025
Common Call Option Sold -33,500 17.5 USD American 19/12/2025
Common Put Option Sold 1,900 17.5 USD American 19/12/2025
Common Put Option Sold 5,400 12.5 USD American 16/01/2026
Common Call Option Sold -900 20.0 USD American 15/01/2027
Common Call Option Sold -227,300 17.5 USD American 21/11/2025

3.             AGREEMENTS TO PURCHASE OR SELL

Full details should be given so that the nature of the interest or position can be fully understood:

Ap33

4.             RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS' AND OTHER EMPLOYEE OPTIONS)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ITPBFBBTMTIMBTA

Talk to a Data Expert

Have a question? We'll get back to you promptly.